• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[伴有和不伴有PTPN11突变的努南综合征患者的表型变异性]

[Phenotype variability in Noonan syndrome patients with and without PTPN11 mutation].

作者信息

Ferreira Lize V, Souza Silvia A L, Montenegro Luciana R, Arnhold Ivo J P, Pasqualini Titania, Heinrich Juan Jorge, Keselman Ana Claudia, Mendonça Berenice B, Jorge Alexander A L

机构信息

Laboratório de Hormônios e Genética Molecular, Disciplina de Endocrinologia do Departamento de Clínica Médica, Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, SP, Brasil.

出版信息

Arq Bras Endocrinol Metabol. 2007 Apr;51(3):450-6. doi: 10.1590/s0004-27302007000300014.

DOI:10.1590/s0004-27302007000300014
PMID:17546245
Abstract

INTRODUCTION

Around 50% of Noonan syndrome (NS) patients present heterozygous mutations in the PTPN11 gene.

AIM

To evaluate the frequency of mutations in the PTPN11 in patients with NS, and perform phenotype-genotype correlation.

PATIENTS

33 NS patients (23 males).

METHODS

DNA was extracted from peripheral blood leukocytes, and all 15 PTPN11 exons were directly sequenced.

RESULTS

Nine different missense mutations, including the novel P491H, were found in 16 of 33 NS patients. The most frequently observed features in NS patients were posteriorly rotated ears with thick helix (85%), short stature (79%), webbed neck (77%) and cryptorchidism (60%) in boys. The mean height SDS was -2.7 +/- 1.2 and BMI SDS was -1 +/- 1.4. Patients with PTPN11 mutations presented a higher incidence of pulmonary stenosis than patients without mutations (38% vs. 6%, p< 0.05). Patients with and without mutations did not present differences regarding height SDS, BMI SDS, frequency of thorax deformity, facial characteristics, cryptorchidism, mental retardation, learning disabilities, GH peak at stimulation test and IGF-1 or IGFBP-3 SDS.

CONCLUSION

We identified missense mutations in 48.5% of the NS patients. There was a positive correlation between the presence of PTPN11 mutations and pulmonary stenosis frequency in NS patients.

摘要

引言

约50%的努南综合征(NS)患者存在PTPN11基因杂合突变。

目的

评估NS患者中PTPN11基因突变频率,并进行表型-基因型相关性分析。

患者

33例NS患者(23例男性)。

方法

从外周血白细胞中提取DNA,对PTPN11基因的全部15个外显子进行直接测序。

结果

在33例NS患者中的16例发现了9种不同的错义突变,包括新发现的P491H突变。NS患者最常见的特征是耳廓后旋伴耳轮增厚(85%)、身材矮小(79%)、蹼颈(77%)以及男孩隐睾(60%)。身高标准差分值(SDS)平均为-2.7±1.2,体重指数SDS为-1±1.4。与无PTPN11基因突变的患者相比,有该基因突变的患者肺动脉狭窄发生率更高(38%对6%,p<0.05)。有突变和无突变的患者在身高SDS、体重指数SDS、胸廓畸形频率、面部特征、隐睾、智力发育迟缓、学习障碍、刺激试验时生长激素峰值以及胰岛素样生长因子-1(IGF-1)或胰岛素样生长因子结合蛋白-3(IGFBP-3)SDS方面均无差异。

结论

我们在48.5%的NS患者中鉴定出了错义突变。NS患者中PTPN11基因突变的存在与肺动脉狭窄频率之间存在正相关。

相似文献

1
[Phenotype variability in Noonan syndrome patients with and without PTPN11 mutation].[伴有和不伴有PTPN11突变的努南综合征患者的表型变异性]
Arq Bras Endocrinol Metabol. 2007 Apr;51(3):450-6. doi: 10.1590/s0004-27302007000300014.
2
PTPN11 mutations are associated with mild growth hormone resistance in individuals with Noonan syndrome.PTPN11突变与努南综合征患者的轻度生长激素抵抗有关。
J Clin Endocrinol Metab. 2005 Sep;90(9):5377-81. doi: 10.1210/jc.2005-0995. Epub 2005 Jun 28.
3
PTPN11 (protein tyrosine phosphatase, nonreceptor type 11) mutations and response to growth hormone therapy in children with Noonan syndrome.PTPN11(蛋白酪氨酸磷酸酶,非受体11型)突变与努南综合征患儿生长激素治疗反应
J Clin Endocrinol Metab. 2005 Sep;90(9):5156-60. doi: 10.1210/jc.2004-2559. Epub 2005 Jun 14.
4
Long-term GH treatment improves adult height in children with Noonan syndrome with and without mutations in protein tyrosine phosphatase, non-receptor-type 11.长期生长激素治疗可提高努南综合征患儿的成年身高,无论其蛋白酪氨酸磷酸酶非受体11型有无突变。
Eur J Endocrinol. 2008 Sep;159(3):203-8. doi: 10.1530/EJE-08-0413. Epub 2008 Jun 18.
5
Noonan syndrome: relationships between genotype, growth, and growth factors.努南综合征:基因型、生长与生长因子之间的关系
J Clin Endocrinol Metab. 2006 Jan;91(1):300-6. doi: 10.1210/jc.2005-0983. Epub 2005 Nov 1.
6
Abnormal growth in noonan syndrome: the challenge of optimal therapy.努南综合征的异常生长:最佳治疗面临的挑战。
Pediatr Endocrinol Rev. 2009 Jun;6 Suppl 4:523-8.
7
Response to growth hormone therapy in children with Noonan syndrome: correlation with or without PTPN11 gene mutation.儿童努南综合征生长激素治疗反应:与 PTPN11 基因突变与否的相关性。
Horm Res Paediatr. 2012;77(6):388-93. doi: 10.1159/000339677.
8
Impact of Growth Hormone Therapy on Adult Height in Patients with PTPN11 Mutations Related to Noonan Syndrome.PTPN11 基因突变相关努南综合征患者生长激素治疗对成人身高的影响。
Horm Res Paediatr. 2019;91(4):252-261. doi: 10.1159/000500264. Epub 2019 May 27.
9
Response to growth hormone in short children with Noonan syndrome: correlation to genotype.努南综合征矮小儿童对生长激素的反应:与基因型的相关性。
Horm Res. 2009 Dec;72 Suppl 2:52-6. doi: 10.1159/000243781. Epub 2009 Dec 22.
10
Analysis of the PTPN11 gene in idiopathic short stature children and Noonan syndrome patients.特发性身材矮小儿童和努南综合征患者中PTPN11基因的分析。
Clin Endocrinol (Oxf). 2008 Sep;69(3):426-31. doi: 10.1111/j.1365-2265.2008.03234.x. Epub 2008 Mar 10.

引用本文的文献

1
Noonan syndrome-causing genes: Molecular update and an assessment of the mutation rate.导致努南综合征的基因:分子学进展及突变率评估
Int J Pediatr Adolesc Med. 2016 Dec;3(4):133-142. doi: 10.1016/j.ijpam.2016.06.003. Epub 2016 Aug 18.
2
Phenotypic spectrum of 80 Greek patients referred as Noonan syndrome and PTPN11 mutation analysis: the value of initial clinical assessment.80 例希腊 Noonan 综合征患者表型谱及 PTPN11 基因突变分析:初始临床评估的价值。
Eur J Pediatr. 2012 Jan;171(1):51-8. doi: 10.1007/s00431-011-1487-5. Epub 2011 May 18.